AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 97.72 million. The enterprise value is 85.99 million.
Market Cap | 97.72M |
Enterprise Value | 85.99M |
Important Dates
The next estimated earnings date is Thursday, November 21, 2024.
Earnings Date | Nov 21, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 119.17 million shares outstanding. The number of shares has increased by 79.64% in one year.
Current Share Class | n/a |
Shares Outstanding | 119.17M |
Shares Change (YoY) | +79.64% |
Shares Change (QoQ) | -15.79% |
Owned by Insiders (%) | 0.34% |
Owned by Institutions (%) | n/a |
Float | 118.77M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.65 |
PB Ratio | 1.92 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -5.79 |
EV / Sales | 12.30 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.63
Current Ratio | 4.63 |
Quick Ratio | 4.20 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -18.31 |
Financial Efficiency
Return on equity (ROE) is -32.89% and return on invested capital (ROIC) is -19.88%.
Return on Equity (ROE) | -32.89% |
Return on Assets (ROA) | -18.92% |
Return on Capital (ROIC) | -19.88% |
Revenue Per Employee | 2.33M |
Profits Per Employee | -4.95M |
Employee Count | 3 |
Asset Turnover | 0.15 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +111.06% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +111.06% |
50-Day Moving Average | 0.94 |
200-Day Moving Average | 0.78 |
Relative Strength Index (RSI) | 36.68 |
Average Volume (20 Days) | 165,757 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 6.99 million and -14.86 million in losses. Loss per share was -0.26.
Revenue | 6.99M |
Gross Profit | -9.33M |
Operating Income | -14.37M |
Pretax Income | -14.86M |
Net Income | -14.86M |
EBITDA | n/a |
EBIT | -14.37M |
Loss Per Share | -0.26 |
Balance Sheet
Cash & Cash Equivalents | 11.73M |
Total Debt | n/a |
Net Cash | 11.73M |
Net Cash Per Share | 0.10 |
Equity (Book Value) | 51.01M |
Book Value Per Share | 0.43 |
Working Capital | 10.39M |
Cash Flow
Operating Cash Flow | -18.38M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is -133.43%, with operating and profit margins of -205.55% and -212.53%.
Gross Margin | -133.43% |
Operating Margin | -205.55% |
Pretax Margin | -212.53% |
Profit Margin | -212.53% |
EBITDA Margin | n/a |
EBIT Margin | -205.55% |
FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -79.64% |
Shareholder Yield | -79.64% |
Earnings Yield | -31.96% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 5.38.
Altman Z-Score | 5.38 |
Piotroski F-Score | n/a |